As to the complexity of NF-kB in NSCLC, further studies are needed to clarify the prognostic value of canonical and non-canonical NF-kB activation pathways in NSCLC patients based on multiple clinical studies in the future. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.